XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaborative Agreement (Details) - USD ($)
 3 Months Ended
May 06, 2016
Dec. 31, 2016
Sep. 30, 2016
Dec. 29, 2015
Collaborative Agreement (Textual)        
Amount received from BriVision   $ 6,500,000 $ 6,500,000  
Accounts payable   18,370  
Collaborative Agreement [Member]        
Collaborative Agreement (Textual)        
Description of payment settlement schedule  

 

 ●upfront payment shall upon the signing of this Collaborative Agreement: 3.5% of total payment. After receiving upfront payment from BriVision, BioLite has to deliver all data to BriVision in one week.
   
 ●upon the first IND submission, BriVision shall pay, but no later than December 15, 2016: 6.5% of total payment. After receiving second payment from BriVision, BioLite has to deliver IND package to BriVision in one week.
   
 ●at the completion of first phase II clinical trial, BriVision shall pay, but no later than September 15, 2017: 15% of total payment. After receiving third payment from BriVision, BioLite has to deliver phase II clinical study report to BriVision in three months.
   
 ●upon the phase III IND submission, BriVision shall pay, but no later than December 15, 2018: 20% of total payment. After receiving forth payment from BriVision, BioLite has to deliver IND package to BriVision in one week.
   
 ●at the completion of phase III, BriVision shall pay, but no later than September 15, 2019:25% of total payment. After receiving fifth payment from BriVision, BioLite has to deliver phase III clinical study report to BriVision in three months.
   
 ●upon the NDA submission, BriVision shall pay, but no later than December 15, 2020, BriVision shall pay: 30% of total payment. After receiving sixth payment from BriVision, BioLite has to deliver NDA package to BriVision in one week.
    
Amount received from BriVision   $ 6,500,000   $ 100,000,000
Upfront payments     $ 3,500,000  
Milestone payments to BioLite in cash $ 2,600,000      
Common stock newly issued, value $ 900,000      
Common stock newly issued, shares 562,500      
Share price $ 1.60      
Licensing rights   3,500,000    
Accounts payable   $ 6,500,000    
Percentage of payments under collaborative agreement   3.50%    
Collaborative Arrangement One [Member]        
Collaborative Agreement (Textual)        
Description of payment settlement schedule   Pursuant to the Collaborative Agreement,6.5% of total payment, $6,500,000 shall be made upon the first IND submission which was submitted in March 2016. $6,500,000 was wholly recorded as accounts payable as of December 31, 2016.    
Licensing rights   $ 6,500,000    
Percentage of payments under collaborative agreement   6.50%